Avicanna Welcomes Initial U.S. Rescheduling of Medical Cannabis & Provides Scientific Update

Rescheduling aligns with Avicanna's established pharmaceutical and medical cannabis strategyRescheduling further supports advancement of R&D, clinical development, and medical affairs initiatives